Hem › Multipelt myelom › Nebraska
Kliniska studier för Multipelt myelom i Nebraska
18 studier för Multipelt myelom söker deltagare vid platser i Nebraska.
Städer i Nebraska
Officiell studietext (engelska)
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
- Nebraska Cancer Specialists, Omaha
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT07518186A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
- Nebraska Cancer Specialists, Omaha
- University of Nebraska Medical Center, Omaha
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT05552222A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant
- NHO Revive Research Institute, LLC, Lincoln
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT05623020TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
- University of Nebraska Medical Center, Omaha
RekryterarFas 2
Ålder 12 och äldre · Alla kön · Uppdaterad 22 sep. 2026 · NCT02693535Study to Assess Safety of HDP-101 in Patients With Relapsed Refractory Multiple Myeloma
- Nebraska Cancer Institute, Omaha
RekryterarFas 1/2
Ålder 18 och äldre · Alla kön · Uppdaterad 17 sep. 2026 · NCT04879043MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
- Bryan Medical Center, Lincoln
- NHO Revive Research Institute, LLC, Lincoln
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 24 aug. 2026 · NCT06152575Improving Cognitive Function in Older Adults Undergoing Stem Cell Transplant
- University of Nebraska Medical Center, Omaha
Rekryterar
Ålder 19 och äldre · Alla kön · Uppdaterad 19 aug. 2026 · NCT04898790Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
- CHI Health Saint Francis, Grand Island
- CHI Health Good Samaritan, Kearney
- Alegent Health Immanuel Medical Center, Omaha
- och 2 fler
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 19 aug. 2026 · NCT04566328A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects
- University of Nebraska, Omaha
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 12 aug. 2026 · NCT07280013A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
- University of Nebraska Medical Center, Omaha
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 6 aug. 2026 · NCT07284758Study Using Prebiotics to Improve Gut Microbiome Diversity After Autologous Cellular Therapy
- Unversity of Nebraska Medical Center, Omaha
Rekryterar
Ålder 19 och äldre · Alla kön · Uppdaterad 27 juli 2026 · NCT05135351A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma
- University Of Nebraska Medical Center, Omaha
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 16 juli 2026 · NCT06121843A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
- NHO Revive Research Institute, LLC /ID# 267869, Lincoln
- Nebraska Cancer Specialists - Omaha - Wright Street /ID# 282497, Omaha
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 13 juli 2026 · NCT05650632Halt Aging in Survivors of Blood Cancers
- University of Nebraska Medical Center, Omaha
Rekryterar
Ålder 50 och äldre · Alla kön · Uppdaterad 1 juli 2026 · NCT07292272Integrated Cancer Repository for Cancer Research
- Mary Lanning Healthcare, Morrison Cancer Center, Hastings
- Faith Regional Health Services, Carson Cancer Center, Norfolk
- Great Plains Regional Medical Center, North Platte
- och 3 fler
RekryterarObservationsstudieFriska volontärer välkomna
Ålder 19 till 110 · Alla kön · Uppdaterad 29 juni 2026 · NCT02012699Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies
- Nebraska Cancer Specialists, Omaha
- University of Nebraska Medical Center, Omaha
RekryterarFas 1/2
Ålder 18 och äldre · Alla kön · Uppdaterad 24 juni 2026 · NCT04068597Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
- CHI Health Good Samaritan, Kearney
- Alegent Health Immanuel Medical Center, Omaha
- Alegent Health Bergan Mercy Medical Center, Omaha
- och 2 fler
RekryterarFas 3
Alla åldrar · Alla kön · Uppdaterad 10 juni 2026 · NCT05561387A Study of Venetoclax in Combination With Isatuximab and Dexamethasone for Relapsed/Refractory Multiple Myeloma
- Nebraska Cancer Specialists, Omaha
RekryterarFas 2
Alla åldrar · Alla kön · Uppdaterad 16 jan. 2025 · NCT06115135Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.